Brokers Set Expectations for McKesson Co.’s Q2 2025 Earnings (NYSE:MCK)

McKesson Co. (NYSE:MCK) – Equities researchers at Leerink Partnrs reduced their Q2 2025 earnings per share estimates for McKesson in a note issued to investors on Monday, October 7th. Leerink Partnrs analyst M. Cherny now expects that the company will earn $6.85 per share for the quarter, down from their previous forecast of $6.89. The consensus estimate for McKesson’s current full-year earnings is $32.07 per share. Leerink Partnrs also issued estimates for McKesson’s Q3 2025 earnings at $8.54 EPS and Q4 2025 earnings at $8.81 EPS.

A number of other research firms have also commented on MCK. Citigroup lowered their price target on shares of McKesson from $670.00 to $630.00 and set a “buy” rating on the stock in a research report on Tuesday, September 10th. StockNews.com cut shares of McKesson from a “buy” rating to a “hold” rating in a report on Friday, September 27th. Mizuho boosted their price target on McKesson from $540.00 to $570.00 and gave the company a “neutral” rating in a research note on Thursday, August 8th. Deutsche Bank Aktiengesellschaft lowered their price objective on McKesson from $623.00 to $579.00 and set a “buy” rating on the stock in a research note on Wednesday, September 25th. Finally, Barclays upped their target price on McKesson from $596.00 to $616.00 and gave the company an “overweight” rating in a research report on Thursday, August 8th. Five analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, McKesson currently has an average rating of “Moderate Buy” and a consensus target price of $610.86.

McKesson Price Performance

MCK stock opened at $483.74 on Tuesday. McKesson has a fifty-two week low of $431.35 and a fifty-two week high of $637.51. The stock has a market capitalization of $62.86 billion, a price-to-earnings ratio of 21.61, a PEG ratio of 1.18 and a beta of 0.44. The business’s fifty day moving average price is $540.73 and its two-hundred day moving average price is $554.35.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, August 7th. The company reported $7.88 earnings per share for the quarter, beating the consensus estimate of $7.21 by $0.67. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. The firm had revenue of $79.28 billion for the quarter, compared to analysts’ expectations of $82.53 billion. During the same period in the prior year, the firm earned $7.27 EPS. The business’s revenue was up 6.4% on a year-over-year basis.

McKesson Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd were paid a $0.71 dividend. This is an increase from McKesson’s previous quarterly dividend of $0.62. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.59%. The ex-dividend date was Friday, August 30th. McKesson’s dividend payout ratio (DPR) is presently 12.69%.

Insider Activity at McKesson

In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of the firm’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $561.10, for a total value of $2,105,808.30. Following the sale, the chief executive officer now owns 78,586 shares in the company, valued at $44,094,604.60. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.11% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of MCK. LRI Investments LLC bought a new position in McKesson in the first quarter valued at about $28,000. Register Financial Advisors LLC bought a new position in McKesson in the 1st quarter valued at approximately $29,000. Richardson Financial Services Inc. acquired a new stake in McKesson during the 4th quarter worth approximately $31,000. Rise Advisors LLC bought a new stake in McKesson during the 1st quarter worth approximately $40,000. Finally, Carmichael Hill & Associates Inc. acquired a new position in McKesson in the 2nd quarter valued at approximately $52,000. 85.07% of the stock is currently owned by institutional investors.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.